Ignite Creation Date:
2024-05-06 @ 3:28 PM
Last Modification Date:
2024-10-26 @ 1:50 PM
Study NCT ID:
NCT04641871
Status:
COMPLETED
Last Update Posted:
2024-06-26
First Post:
2020-10-29
Brief Title:
Sym021 in Combination With Either Sym022 or Sym023 or Sym023 and Irinotecan in Patients With Recurrent Advanced Selected Solid Tumor Malignancies
Sponsor:
Symphogen AS
Organization:
Symphogen AS
Organization Data
Organization:
Symphogen AS
Class:
INDUSTRY
Study ID:
Sym021-02
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Symphogen AS
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None